Business:
Reformulated, Topical Dermatology Products
Drug notes:
Also Clin3 atopic dermatitis; Romflumilast foam Clin3 seborrheic dermatitis, Clin3 psoriasis; ARQ-255 Clin1 alopecia areata; ARQ-252 Clin0 hand eczema, Clin0 vitiligo; ARQ-234 Clin0 atopic dermatitis
About:
Arcutis Biotherapeutics is developing small molecule therapeutics for the treatment of immune-mediated dermatological diseases. Skin diseases like dermatitis, psoriasis and eczema are united by their immune-mediated pathology. Arcutis is using their deep medical dermatology expertise and a unique drug development platform to create topical product therapies for patients with these conditions. With this platform, Arcutis is building a robust pipeline that includes molecules developed from key targets of inflammatory dermatological conditions such as PDE4 and JAK1. These formulations have achieved significant results in their clinical trials for Atopic Dermatitis with multiple other clinical programs in development.
PAM Great Lakes United States|6 days ago
Overlay Therapeutic Sales Specialist - Arlington United States|10 days ago
Overlay Therapeutic Sales Specialist - Long Island... United States|10 days ago
Therapeutic Sales Specialist - Charleston United States|10 days ago
Overlay Therapeutic Sales Specialist - Hartford United States|18 days ago
TSS Phoenix South United States|28 days ago
TSS Sacramento United States|41 days ago
Regional Sales Dir South Atlantic United States|46 days ago
Dir Trade Relations United States|53 days ago
OTSS Kansas City/Nebraska United States|69 days ago